IMVT
Price
$29.47
Change
-$1.00 (-3.28%)
Updated
Oct 12, 04:59 PM (EDT)
Capitalization
6.92B
37 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$34.59
Change
-$0.85 (-2.40%)
Updated
Oct 12, 04:59 PM (EDT)
Capitalization
26.71B
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMVT vs ROIV

IMVT vs ROIV Comparison Chart in %
View a ticker or compare two or three
VS
IMVT vs. ROIV commentary
Oct 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and ROIV is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
IMVT vs ROIV: Fundamental Ratings
IMVT
ROIV
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
5815
SMR RATING
1..100
9892
PRICE GROWTH RATING
1..100
5641
P/E GROWTH RATING
1..100
10042
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMVT's Valuation (51) in the null industry is somewhat better than the same rating for ROIV (86). This means that IMVT’s stock grew somewhat faster than ROIV’s over the last 12 months.

ROIV's Profit vs Risk Rating (15) in the null industry is somewhat better than the same rating for IMVT (58). This means that ROIV’s stock grew somewhat faster than IMVT’s over the last 12 months.

ROIV's SMR Rating (92) in the null industry is in the same range as IMVT (98). This means that ROIV’s stock grew similarly to IMVT’s over the last 12 months.

ROIV's Price Growth Rating (41) in the null industry is in the same range as IMVT (56). This means that ROIV’s stock grew similarly to IMVT’s over the last 12 months.

ROIV's P/E Growth Rating (42) in the null industry is somewhat better than the same rating for IMVT (100). This means that ROIV’s stock grew somewhat faster than IMVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMVTROIV
RSI
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
66%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 21 days ago
77%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 5 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 5 days ago
55%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
82%
COMPARISON
Comparison
Oct 12, 2026
Stock price -- (IMVT: $30.47 vs. ROIV: $35.44)
Brand notoriety: IMVT and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 112% vs. ROIV: 64%
Market capitalization -- IMVT: $6.92B vs. ROIV: $26.71B
IMVT [@Biotechnology] is valued at $6.92B. ROIV’s [@Biotechnology] market capitalization is $26.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green while ROIV’s FA Score has 1 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 3 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • IMVT’s TA Score: 3 bullish, 3 bearish.
  • ROIV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than ROIV.

Price Growth

IMVT (@Biotechnology) experienced а -9.37% price change this week, while ROIV (@Biotechnology) price change was -0.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.01%. For the same industry, the average monthly price growth was -11.51%, and the average quarterly price growth was -11.49%.

Reported Earning Dates

IMVT is expected to report earnings on Nov 18, 2026.

ROIV is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-5.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IMVT
Daily Signal:
Gain/Loss:
ROIV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOC18.800.28
+1.51%
Healthpeak Properties
SSII2.640.01
+0.57%
SS Innovations International Inc
BWEN3.870.01
+0.26%
Broadwind
BBAR12.65-0.04
-0.32%
Banco BBVA Argentina SA
NCNA1.10-0.03
-2.65%
NuCana plc

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+0.69%
ROIV - IMVT
62%
Loosely correlated
+3.60%
KURA - IMVT
53%
Loosely correlated
+0.76%
SYRE - IMVT
46%
Loosely correlated
+7.25%
NRIX - IMVT
45%
Loosely correlated
+0.63%
XNCR - IMVT
43%
Loosely correlated
+0.53%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+3.60%
IMVT - ROIV
62%
Loosely correlated
+0.69%
AXON - ROIV
43%
Loosely correlated
+1.34%
DNTH - ROIV
42%
Loosely correlated
-0.07%
IMTX - ROIV
41%
Loosely correlated
+0.81%
MLYS - ROIV
40%
Loosely correlated
+4.42%
More